Eva Barnett
Vermögen: 11 Mio $ am 31.05.2026
Vermögen: 11 Mio $ am 31.05.2026
Eva Renee Barnett formerly worked at Immunovant, Inc., as Chief Financial & Accounting Officer from 2021 to 2025, Eli Lilly & Co., as Chief Financial Officer-Austria & Switzerland from 2011 to 2012, and AbleTo, Inc., as Chief Integration Officer in 2021.
Ms. Barnett received her undergraduate degree from DePauw University and Masters Business Admin degree from Harvard Business School.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
IMMUNOVANT INC 0,16 % | 13.06.2025 | 327.119 ( 0,16 % ) | 11 Mio $ | 31.05.2026 |
| Unternehmen | Position | Ende |
|---|---|---|
| IMMUNOVANT, INC. | Finanzdirektor/CFO | 20.04.2025 |
AbleTo, Inc.
AbleTo, Inc. Medical/Nursing ServicesHealth Services Provides online therapy and coaching services for mental health conditions | Finanzdirektor/CFO | 01.03.2018 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01.08.2012 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
AbleTo, Inc.
AbleTo, Inc. Medical/Nursing ServicesHealth Services Provides online therapy and coaching services for mental health conditions | Health Services |
DePauw University
DePauw University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immunovant, Inc.
Immunovant, Inc. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen